title: Dramatic reduction in sandimmune (CyA) dosage may be effective in reversal of severe hyperbilirubinemia and post-transplant acute kidney failure linked to CyA toxicity.
authors.affiliation: Department of Nephrology, Medical Academy of Wrocław, Poland.
authors.forename: Z
authors.initials: Z
authors.lastname: Szewczyk
authors.forename: Z
authors.initials: Z
authors.lastname: Hruby
authors.forename: J
authors.initials: J
authors.lastname: Uzar
authors.forename: K
authors.initials: K
authors.lastname: Skóra
authors.forename: Z
authors.initials: Z
authors.lastname: Szydłowski
authors.forename: W
authors.initials: W
authors.lastname: Witkiewicz
authors.forename: D
authors.initials: D
authors.lastname: Patrzałek
mesh_terms: D058186:Acute Kidney Injury / Q000188:drug therapy; D000328:Adult; D003524:Cyclosporins / Q000008:administration & dosage*; D005260:Female; D006801:Humans; D006932:Hyperbilirubinemia / Q000188:drug therapy; D016030:Kidney Transplantation; D016031:Liver Transplantation; D008297:Male; D008875:Middle Aged; D011183:Postoperative Complications / Q000188:drug therapy
chemical_list: D003524:Cyclosporins